ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JOSEPH OFSTEDAL MD

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,427Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 1942

$781K Total Retail Price of All Prescriptions

Rank: 9 out of 1942

453 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 453 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 453 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,607 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 457 372 1 2
OMEPRAZOLE 361 287 2 4
FUROSEMIDE 280 232 3 5
HYDROCODONE-ACETAMINOPHEN 274 145 S3 4 12
LEVOTHYROXINE SODIUM 259 228 5 3
SIMVASTATIN 255 215 6 1
ZOLPIDEM TARTRATE 246 147 7 25
AMLODIPINE BESYLATE 208 179 8 6
GABAPENTIN 200 133 9 16
CITALOPRAM HBR 186 171 10 15
OXYCODONE-ACETAMINOPHEN 182 71 S2 11 56
LOSARTAN POTASSIUM 178 155 12 18
HYDROCHLOROTHIAZIDE 175 156 13 8
FLUTICASONE PROPIONATE 148 104 14 37
ATORVASTATIN CALCIUM 144 133 15 14
METOPROLOL SUCCINATE 141 115 16 13
ATENOLOL 130 113 17 7
POLYETHYLENE GLYCOL 3350 122 91 18 28
ALENDRONATE SODIUM 117 98 19 21
TRAZODONE HCL 105 69 20 24
OXYCONTIN 103 50 S2 21 84
METFORMIN HCL ER 97 56 22 46
TRAMADOL HCL 95 82 23 19
WARFARIN SODIUM 94 64 24 11
ROPINIROLE HCL 93 85 25 96
CYCLOBENZAPRINE HCL 87 51 R 26 73
RANITIDINE HCL 84 63 27 31
METOPROLOL TARTRATE 84 73 27 9
POTASSIUM CHLORIDE 84 30 27 17
LIDODERM 84 73 27 98
OXYCODONE HCL 83 30 S2 31 52
NEXIUM 81 40 32 58
SERTRALINE HCL 76 54 33 20
ALLOPURINOL 74 64 34 26
TRIAMCINOLONE ACETONIDE 70 56 35 71
PROAIR HFA 69 38 36 41
PANTOPRAZOLE SODIUM 67 47 37 48
JANTOVEN 64 58 38 33
PRAVASTATIN SODIUM 63 48 39 23
FENTANYL 62 38 S2 40 47
SINGULAIR 62 42 40 164
MIRTAZAPINE 60 50 42 38
DONEPEZIL HCL 60 60 42 30
TRIAMTERENE-HCTZ 60 54 42 36
GLIPIZIDE ER 60 60 42 80
IBUPROFEN 60 30 42 78
METHOCARBAMOL 59 0 R 47 246
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 0 48 104
GLIPIZIDE XL 57 57 49 109
DIGOXIN 52 42 50 40
CYMBALTA 52 0 50 62
TAMSULOSIN HCL 52 26 50 29
CLOPIDOGREL 52 50 50 55
BUPROPION XL 50 26 54 131
METHYLPREDNISOLONE 50 40 54 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.